There are rare exceptions. Sometimes a parent carries the change in only a small part of their body's cells. This is called mosaicism, and that parent may have few or no signs of the syndrome. Because of such exceptions, a talk with a genetic counsellor is important when a family wants to know the chance of it happening again. A person who has HVDAS does carry the change in one copy of the gene. If they have children one day, each child has a 50% chance of inheriting it, which is supported by generation of several mouse models.
Same diagnosis, different children
Children with HVDAS can differ a lot in their development, health and abilities, even when their genetic changes look alike (Van Dijck et al., 2019; Levine et al., 2024). The exact change in ADNP is probably an important part of the explanation, but not the whole story. A child's other genes, how their brain develops and their surroundings may all play a part. Researchers are studying whether certain types or positions of changes go with certain features. Some links have been found, but doctors cannot yet predict a child's future from their genetic change alone.
What a genetic diagnosis tells you
HVDAS is diagnosed when a disease-causing change in ADNP is found in a child whose features fit the syndrome. Genetic testing matters because the signs of HVDAS overlap with many other developmental conditions.
Some laboratories can also look at an episignature: a pattern of small chemical tags on the DNA in a blood sample. Children with HVDAS tend to fall into two main patterns, depending on where in the gene their change sits (Bend et al., 2019; Breen et al., 2020). This can help confirm a diagnosis when a change is hard to interpret.
For families, a diagnosis can:
• give an explanation for their child's difficulties
• guide medical care and genetic counselling
• connect them with other families and the ADNP research community
It cannot yet tell exactly how a child will develop, or which treatment will work best.
What researchers learn from these changes
Each genetic change is also a clue about how ADNP works. By studying changes in cells and animal models, researchers learn which parts of the protein matter most and what goes wrong inside the cell (see "The Molecular Biology of ADNP").
Genetics tells us which changes cause HVDAS. Molecular biology tells us what those changes do. Together, they are the path towards better ways to help children with HVDAS.
Key words




The Genetics of ADNP-related Helsmoortel-Van der Aa syndrome
ADNP-related Helsmoortel-Van der Aa syndrome (HVDAS), unofficially named the ADNP syndrome, is caused by a change in one gene: the Activity-Dependent Neuroprotective Protein (ADNP) gene. This page explains, in everyday words, what that change is, why it usually appears in a child out of the blue, and why no two children are exactly alike. You do not need any background in biology to read it. Difficult words are explained along the way and collected at the bottom of the page.
One changed copy of the gene is enough
Our body is built and run from instructions stored in our DNA. A gene is one of those instructions: a recipe that tells the cell how to make one particular protein. The ADNP gene holds the recipe for the ADNP protein, which helps switch other genes on and off while the brain and body develop.
We carry two copies of almost every gene, one from each parent. In HVDAS, one copy of ADNP carries a change and the other copy is normal. Geneticists call this a heterozygous variant: a change (also called a mutation or variant) in one of the two copies. Although one copy of the ADNP gene remains normal, the change in the other copy is enough to interfere with ADNP’s function. Exactly how this happens inside cells is still being investigated (see "The Molecular Biology of ADNP").
Most changes make a shortened ADNP protein
Think of the gene as a long sentence the cell reads from start to finish. In most children with HVDAS, the change puts a "stop" sign too early in that sentence or shifts the way the letters are read so that a stop sign soon appears. The cell then makes a protein that is cut short. Geneticists call these truncating variants.
How a truncating change in one copy of ADNP leads to a shortened protein: the normal copy still makes full-length protein. The changed copy stops early and makes a shorter one. Most of these changes sit in the last and largest part of the gene (the last exon), which holds most of the recipe for the protein. Some changes have been found again and again in unrelated children. The best known are written as p.Tyr719*, p.Arg730*, and p.Asn832Lysfs*81 (Helsmoortel et al., 2014; Van Dijck et al., 2019; Harutyunyan et al., 2025). These repeated changes are sometimes called hotspots. This does not mean every child has the same change. It tells us that these parts of the protein are especially important for its job.
Not every change in ADNP causes the syndrome
Shortened-protein changes explain most diagnoses, but other kinds of change exist too.
• Splicing changes. Before a recipe is used, the cell cuts and pastes its pieces together, a step called splicing. In one child, a new change just outside the recipe itself disturbed this step, so too little working ADNP protein was made (D'Incal et al., 2024).
• Missense changes. These swap a single building block (an amino acid) of the protein for another one. They are much harder to interpret. One such change has been linked to a milder developmental picture (Gozes & Shazman, 2023) but has not been investigated experimentally.
Finding a missense change in ADNP does not automatically mean it causes HVDAS. Everyone carries small genetic differences that are harmless. Geneticists need extra evidence before they call a change disease-causing.
The key message: a change in the ADNP gene is not always a disease-causing change. Your clinical geneticist can explain what is known about your child's specific change.
Why HVDAS usually appears out of the blue
In most children, the change in ADNP is new. It was not passed down from either parent. Geneticists call this a de novo change, Latin for "from the beginning" (Helsmoortel et al., 2014; Van Dijck et al., 2019). A de novo change happens by chance in the egg or sperm cell, or very early after fertilization. Nothing the parents did, or did not do, caused it. This is why parents usually do not carry the change when their blood is tested, and why there is often no one else in the family with similar difficulties.


References
• Bend, E. G., et al. (2019). Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome. Clinical Epigenetics, 11(1), 64. doi:10.1186/s13148-019-0658-5
• Breen, M. S., et al. (2020). Episignatures stratifying Helsmoortel-Van der Aa syndrome show modest correlation with phenotype. American Journal of Human Genetics, 107(3), 555–563. doi:10.1016/j.ajhg.2020.07.003
• D'Incal, C., et al. (2024). ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case. Acta Neuropathologica Communications, 12(1), 62. doi:10.1186/s40478-024-01743-w
• Gozes, I., & Shazman, S. (2023). A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome. European Journal of Neuroscience, 58(2), 2641–2652. doi:10.1111/ejn.15920
• Harutyunyan, L., Kooy, R. F., D'Incal, C. P., & Van Dijck, A. ADNP-related Helsmoortel-Van der Aa syndrome. In: GeneReviews®. University of Washington, Seattle, 1993–. NBK355518
• Helsmoortel, C., et al. (2014). A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nature Genetics, 46(4), 380–384. doi:10.1038/ng.2899
• Levine, J., et al. (2024). Longitudinal genotype-phenotype (Vineland questionnaire) characterization of 15 ADNP syndrome cases. Journal of Molecular Neuroscience, 74(1), 15. doi:10.1007/s12031-024-02189-4
• Van Dijck, A., et al. (2019). Clinical presentation of a complex neurodevelopmental disorder caused by mutations in ADNP. Biological Psychiatry, 85(4), 287–297. doi:10.1016/j.biopsych.2018.02.1173
